WATERTOWN, Mass., Feb. 5, 2018 /PRNewswire/ -- SQZ Biotech (SQZ), a preclinical stage biotechnology company developing celltherapies based on its proprietary CellSqueeze® technology, announced today that management will be presenting at three investor conferences in the first quarter of 2018.
BIO CEO and Investor Conference in New York, NY
Cowen and Company Annual Healthcare Conference in Boston, MA March 12 – March 14, 2018 Presentation Time: March 12, 2018 at 2:30pm
Oppenheimer Annual Healthcare Conference in New York, NY March 20 – March 21, 2018 Presentation Time: March 21, 2018 at 8:35am
"We are thrilled to have the opportunity to present SQZ's vision of developing a new generation of cell-based therapies," remarked Armon Sharei, PhD, CEO at SQZ. "It is an honor to be selected as a private company and we look forward to discussing our potential to implement previously inaccessible therapies across multiple disease areas."
About SQZ Biotech SQZ Biotechnologies is a Massachusetts-based, privately held company developing cellular therapies for multiple indications using the proprietary CellSqueeze® technology. Through internal research programs and external partnerships, SQZ's unique cell engineering capabilities are being used to develop a new generation of cell therapies to address a wide range of clinical challenges. For more information please visit www.sqzbiotech.com.
SQZ Contact: Rebecca Cohen Manager, Corporate Relations & Administration email@example.com 617-758-8672 ext. 728
SQZ Media Contact: Justin Jackson Burns McClellan 212-213-0006, ext. 327 firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/sqz-biotech-to-present-at-investor-conferences-in-first-quarter-2018-300593144.html
SOURCE SQZ Biotechnologies
Subscribe to our Free Newsletters!
Inguinal hernia surgery is a procedure to repair a weak spot or defect in the lower wall of the ...
Hypopituitarism is a rare disorder resulting from decreased secretion of one or more of the ...
Palliative care is a specialized multifaceted care for patients with chronic or terminal illness to ...View All